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ABSTRACT 
The aim of this study was to determine the inhibition effects of the terpenoid of Plantago major on calcium oxalate 
crystals in vitro and to compare the effects of Plantago major with clinically used drugs like zyloric and potassium 
citrate for the treatment of urinary stone. Modified Schneider slide gel method was used for in vitro study and crystals 
formed were measured by Image Analyser System (Leica) after 24 h of treatment. The active compound in the methanol 
extract of Plantago major was isolated by bioassay - guided fractionation & isolation method. Dimethylsulphoxide 
(DMSO) was used as the negative control and zyloric and potassium citrate were used as positive controls. The results 
showed that crude methanol extract of Plantago major contained the active compound terpenoid. Terpenoid, zyloric and 
potassium citrate at concentrations in the range of (100 µg/mL - 250 µg/mL) significantly inhibited the area of crystal 
formation in comparison to the negative control after 24 h (p<0.001). The Zyloric and terpenoid of Plantago major in 
the concentrations of (100 µg/mL-250 µg/mL) inhibited the sizes of crystals significantly (p<0.05). Potassium citrate 
was more effective, than terpenoid of Plantago major in inhibiting the size of crystals at two concentrations i.e. 100 µg/
mL and 150 µg/mL respectively (p<0.05). However the IC
50
 values for terpenoid of Plantago major, potassium citrate 
and zyloric were 250 µg/mL, 300 µg/mL and 550 µg/mL, respectively. The inhibition effect of the terpenoid of Plantago 
major extract on crystal size was much better than Zyloric and potassium citrate. 
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ABSTRAK
Kajian ini bertujuan untuk menentukan kesan perencatan sebatian terpenoid daripada ekstrak metanol Plantago major 
terhadap kristal kalsium oksalat in vitro dan seterusnya membandingkan kesan Plantago  major dengan dadah Zyloric 
and potassium citrate. Pada masa kini, kedua-dua dadah ini digunakan untuk merawat batu buah pinggang. Modifikasi 
kaedah Schneider slaid bergel telah digunakan untuk kajian in vitro. Selepas 24 jam, pembentukan hablur telah diukur 
menggunakan Sistem Analisis Imej (Leica). Sebatian aktif dalam ekstrak metanol Plantago major telah diisolasikan 
menggunakan kaedah Bioassay – fraksinasi terarah dan isolasi. Dimethilsulfhoksid (DMSO) telah digunakan sebagai 
kawalan negatif manakala Zyloric dan kalium sitrat pula telah digunakan sebagai kawalan positif. Keputusan kajian 
menunjukkan bahawa ekstrak Plantago major yang mengandungi compound terpenoid, zilorik dan kalium sitrat pada 
julat kepekatan 100 mg/mL-250 mg/mL berupaya secara statistik merencat pembentukkan kristal berbanding kawalan 
negatif selepas 24 jam (p<0.001). Perencatan perkembangan saiz kristal turut dikesan pada Terpenoid daripada Plantago 
major berbanding Zyloric pada kesemua kepekatan kajian (p<0.05). Kalium sitrat telah didapati lebih berkesan daripada 
Plantago major dalam merencat pembentukan hablur pada dua kepakatan iaitu 100 mg/mL dan 150 mg/mL (p<0.05). 
Walaupun begitu nilai IC
50
 untuk terpenoid, kalsium sitrat dan zyloric berada pada 250 mg/mL, 300 mg/mL dan 550 
mg/mL. Kesan perencatan sebatian terpenoid dalam ekstrak Plantago major didapati lebih baik berbanding dengan 
zilorik dan kalsium sitrat.  
Kata kunci: Kesan inhibitori; hablur kalsium oksalat; Plantago major; sebatian terpenoid
 There are two types of calcium oxalate crystals i.e. 
monohydrate type (in the form of dump bell or oval in 
shape) and the dihydrate type (in the form of double 
pyramid ) (Kannabiran & Selva 1997). 
 The cause is multifactorial including diet, genetic and 
environment (Anderson 1979). Many treatments have been 
tried for the treatment of urolithiasis in Malaysia and other 
parts of the World. It recurs back within five years (50%) 
INTRODUCTION
Urolithiasis is a condition of formation of calculus in the 
urinary system, i.e. in the kidney, ureter, urinary bladder 
or in the urethra (Shakarriz & Marshal 2001). Generally 
there are five different types of stones of which calcium 
oxalate is the most common (80%), struvite stone (10%), 
uric acid stone (9%) and (1%) is due to cystine and 
ammonium urate (Coe et al. 2005). 
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and there is not one standard treatment that can prevent 
the recurrences (Burkhill 1994). 
 Plantago major Linn. belonging to the family 
Plantaginaceae is a perennial herb which was found 
wild throughout the whole of Europe and temperate Asia 
(Burkill 1966). Every part of the plant has been used in 
many traditional medicines to treat cough, diarrhoea, 
dysentery and urinary tract calculus (Burkill 1966; Mabey 
1988; Muhamad et al. 1994). Zyloric (Allopurinol) is a 
uricosuric agent that has been clinically used for the follow 
up patients with stone as it reduced the production of uric 
acid in urine and in fact uric acid may be a nidus for calcium 
oxalate crystals (Ismail et al. 1984). Potassium citrate is a 
low molecular weight inhibitor for crystallization (Meyer 
& Smith 1975). 
 The present study is on the inhibiting effects of 
terpenoid of Plantago major in vitro and to compare the 
effects of this extract with the clinically used drugs like 
zyloric and potassium citrate. 
ExPERIMENTAL DETAILS
The whole plant (stem, leaves and roots) was collected 
from Air Itam, Penang and was identified by the botanist 
from Forest Research Institute of Malaysia (FRIM) where a 
voucher specimen was deposited. The herbarium registered 
number in FRIM is ZAS -1073/ SEPT. 2004. The fresh sample 
was washed, cut into small pieces and dried at room 
temperature for a week. The sample was ground into fine 
powder and Soxhlet extracted with methanol. Different 
concentrations of the extract were prepared by diluting 
with DMSO (dimethylsulfoxide) 100 ppm, 150 ppm, 200 
ppm, 250 ppm (1 ppm =1 μ/mL). One and half milliliter 
of one percent (1%) bactoagar was heated to liquefy and 
then smeared on the clean glass slides and each slide was 
divided into two equal areas whereby eight equal wells 
(spacing between wells was 0.5 cm × 1.25 cm) were made 
in the gel when the gel was about to solidify (Schneider et 
al. 1983). The slides prepared were divided into negative 
control (DMSO only) (n=10), positive controls (zyloric & 
potassium citrate) (each n=10), Plantago major extract 
(n=10). For the production of calcium oxalate crystals, 
20 uL of 0.2 M calcium chloride and 20 uL of ammonium 
oxalate was introduced in the opposite wells and the 
samples to be studied were put in the two longitudinal 
wells. The area and size of the crystal were measured after 
24 h by using Image Analyzer System KS 300, 3.0 Leica. 
The magnification was 320X.  
IDENTIFICATION OF ACTIvE COMPOUND 
SOLvENT PARTITIONING
The separation method of crude extract of Plantago major 
based on the polarity of the components known as solvent 
partitioning. In this study, crude extract was divided into 
5 other different extracts like hexane, chloroform, ethyl 
acetate and aqueous extracts. 
 About 700 mL of distilled water was poured into a 
beaker containing crude extract of Plantago major. The 
crude extract of P. major was dissolved in distilled water 
was then transferred into a separating funnel (700 mL).
Hexane solution was then introduced into the separating 
funnel. The separating funnel was then stoppered and 
shaken for 5 min to allow the components in the solution 
to be extracted by hexane. 
 After hexane extraction was done, chloroform 
extraction was done followed by extraction of ethyl acetate. 
The steps in extraction of chloroform and ethyl acetate 
were the same as that for hexane extraction. Chloroform 
extract differs from hexane and ethyl acetate extracts 
as chloroform extract has a higher density compared to 
aqueous extract. Thus, chloroform extract was found below 
the aqueous layer.
 At the end of the extraction process, the remaining 
aqueous extract was collected after obtaining the acetyl 
acetate extract. Each extract collected was dried using 
FIGURE 2. Modified Schneider slide gel method in making 2 areas of crystal formation at one slide
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rotavapour at 45°C, except for aqueous extract which was 
dried at 50°C.
PROCESS BIOASSAy- GUIDED FRACTIONATION & ISOLATION 
OF ACTIvE COMPOUND
Bioassay –guided fractionation process was a step to test 
the activity of sample extract of P. major. Flow chart of 
bioassay-guided fractionation process and separation of 
the active compound is shown in Figure 2. The activity 
of hexane, chloroform, ethyl acetate and aqueous extracts 
obtained by solvent partitioning were tested and the one 
with the highest activity was selected for further separation. 
The first level activity test showed that the aqueous extract 
has the highest activity. Activity test was done by modified 
gel slide method of Schneider et al. (1983). 
 Aqueous extract was selected to undergo further 
separation in order to get the active compound in P. major 
that was actively inhibiting the formation of crystals in 
vitro. Chromatography column was used in the separation 
process of active compound. The initial separation used 
Diaion HP2Oss column. A total of 7 fractions were obtained 
by Diaion HP2Oss column. Activity test done showed that 
the 5th fraction (A5) was the most active fraction.
 Fraction A5 being most active was selected for further 
separation in order to obtain a single active compound. 
Further separation was carried out by Chromatography 
column using ODS column (Chromatorex) and sulphadex 
LH20 were used. A total of 8 fractions were obtained 
using this column. The 4th fraction (A51V) was the most 
active fraction. Thin layer chromatography (TLC) was 
used to identify the active compound in A51V which can 
effectively inhibit the formation of crystals in vitro.
IDENTIFICATION OF ACTIvE COMPOUND 
IN PLAnTAgO MAjOr
Thin Layer Chromatography (TLC) was used to identify 
the active compound in this study. TLC plate measuring 
(4 × 5 cm2) was prepared. A spot was marked on the plate 
FIGURE 2. Bioassay-guided Isolation of Active compound in the 
methanol extract of Plantago major
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about 0.5 cm from the bottom end of the plate. Capillary 
tube was used to transfer 3 drops of the sample to the 
drop that has been drawn. Then the plate was introduced 
into a beaker filled with solvent (chloroform : methanol : 
distilled water = 7:3:0.5) that serves as the moving phase. 
The beaker was covered and when the solvent has moved 
about 0.5 cm from the upper end of the plate, the plate was 
taken out and dried.
 The TLC plate was observed under Uv light and spots 
seen on the plates was identified. Next, the plate was 
sprayed with sulphuric acid 10% and warmed on hot plate. 
Colored patches were produced and the active compound 
present was identified based on the color of the patches 
(eg. Terpenoid- pink to purple/violet colour).
 IC50 was determined by finding out the concentration 
of terpenoid, zyloric and potasium citrate which can reduce 
the size of calcium oxalate crystals to about half the size 
mean size of normal control (i.e DMSO) (Table 1).
RESULTS AND DISCUSSION
The calcium oxalate crystals that have been produced in 
this in vitro study were similar to the crystals in the urine 
of patient with calcium oxalate crystals (Zhari et al. 1995). 
Most of the crystals measured in this study were calcium 
oxalate (dihydrate type) since 90% of monohydrate type 
were formed only after 48 h Dimethyl sulphoxide (DMSO) 
was used as control since DMSO was widely used as 
industrial solvent for both organic and inorganic chemicals 
(Whillhite & Datz 1984).
 In this study methanol extract of Plantago major 
has been used since many of the active compounds in the 
plants were dissolved in it and can be extracted. Because 
the polarities of four different solvents like hexane, 
chloroform, ethyl acetate and aqueous are different, the 
active compound in them is also different (Fasihuddin & 
Hasmah 1993). The results of the in vitro inhibition effects 
of different concentrations of terpenoid of Plantago major, 
Zyloric and potassium citrate on the area of calcium oxalate 
crystal formation after 24 hours were shown in Table 
2. This study showed that Plantago major, Zyloric and 
potassium citrate at concentrations of 100, 150, 200, 250 
μg/mL significantly inhibited the area of crystals formation 
when compared to negative control after 24 h (p<0.001). 
Terpenoid of Plantago major was more effective in 
reducing the area of crystal formation compared to 
TABLE 2. Inhibition effects of terpenoid of Plantago major, Zyloric and  potassium citrate at different concentrations on area of calcium 
oxalate crystal  formation after 24 hours in vitro. * p<0.001 vs control, # p<0.05 vs extract of Plantago major (unpaired t-test)
Sample n Different concentrations in 
(μg/mL)
Area of crystal formation in mm2 
(mean+S.E.M).
Terpenoid of Plantago major
Zyloric (positive control)
Potassium citrate (positive control)
DMSO (negative control)
10
10
10
10
100
150
200
250
100
150
200
250
100
150
200
250
100
150
200
250
7.71+0.2 *
7.05+0.2 *
5.62+0.3 *
5.32+0.3 *
7.5+0.5 *
6.7+0.3 *
6.05+0.3 *
5.6+0.3 *
8.7+0.5 *
7.7+0.3 *
6.6+0.2 *#
6.4+0.3 *#
11.93+1.63
11.49+1.55
11.59+1.39
11.84+1.26
Clearance – S.E.M means standard error of mean
TABLE 2. IC
50
 values of the terpenoid of Plantago major, Zyloric and potassium 
 citrate on the size of calcium oxalate crystals after 24 hours in vitro
Sample IC
50
values 
(µg/mL).
Mean size crystal
(µm2)
DMSO (negative control) - 147.68+3.5
Terpenoid of Plantago major 250 73.95+4.4
Zyloric (positive control). 550 72.3+2.95
Potasiium citrate (positive control) 300 74.9+5.1
Clearance = IC
50
value is the inhibitory concentration of the tested compound  which can reduce the mean size of calcium 
oxalate crystals to half the size or nearly half the size of that of control (i.e DMSO)
  37
potassium citrate at 200 and 250 μg/mL (p<0.05), whereas 
there were no significant differences between the effects 
of Zyloric and Plantago major. The exact mechanism of 
action is not known but the active ingredient in Plantago 
major may have inhibited the growth or aggregation of 
the crystals or it may have dissolved the preformed crystal 
(Zhari et al. 1995). 
 Table 3 shows the inhibitory effects of terpenoid of 
Plantago major, zyloric and potassium citrate on the size 
of each crystal (dihydrate variety) as compared to control. 
The reduction in the size of calcium oxalate crystals by 
Plantago major was greater compared to zyloric at all 
concentrations tested (p<0.05). Potassium citrate was 
more effective than Plantago major in reducing the crystal 
size at the lower concentrations of 100 and 150 μg/mL. 
However, IC
50
 values of terpenoid of Plantago major, 
potassium citrate and zyloric were 250 μg/mL, 300 μg/mL 
and 550 μg/ml respectively for the reduction of crystal size 
(Table 1). The results indicated that terpenoid of Plantago 
major was much better than zyloric and potassium citrate 
in reducing the size of the crystals. Abramson (1992) has 
identified polysaccharides, fat, caffeine acid derivatives, 
flavonoids, glycosides, irinoid and terpenoids. In this study 
the active ingredient in Plantago major that has inhibition 
effects on the area and size of calcium oxalate crystals 
was terpenoid. Calcium oxalate crystals (dihydrate type) 
that has been inhibited in sizes by all four groups studied 
in this research is shown in Figure 3. Comparing the 
size of crystals, the most effective reduction on the size 
of crystal was terpenoid followed by potassium citrate 
and zyloric. Terpene is a one of the important secondary 
metabolites in plants. When terpene is modified chemically, 
it is called terpenoid. There are variety of terpene namely 
monoterpene, diterpene, sequisterpene and others. Plant 
terpenoids are used extensively for their aromatic qualities. 
They play a role in traditional herbal remedies and are 
under investigation for antibacterial, antineoplastic, and 
other pharmaceutical functions. Terpenoids contribute to 
the scent of eucalyptus. Plantago major has been found 
to contain iridoid glycosides of which aucubin is a major 
triterpenes (Ibrahim 2006). 
CONCLUSION
In conclusion the significant inhibiting effect of the 
terpenoid of Plantago major on the area of calcium 
oxalate stone formation was observed at 100μg/mL 
onwards (p<0.001) with an IC
50 
value of the terpenoid 
being 250 μg/mL. Therefore the effect of terpenoid from 
methanol extract of Plantago major was more effective 
than zyloric and potassium citrate in inhibiting the sizes 
of calcium oxalate crystals in vitro. In conclusion the 
active compound in methanol extract of Plantago major 
that inhibited the area of formation and size of calcium 
oxalate crystals was compound terpenoid and effect of 
compound terpenoid was much better that zyloric and 
potassium citrate.
 Further study the effect of compounds in Plantago 
major extract on urine of urolithiatic patients to see how 
effective it is on crystals of stone patient and also clinical 
trials are needed on the human beings with calcium oxalate 
urolithiasis. There may be a potential for using alternative 
medicine for patients with urolithiasis apart from surgery 
and western medicines which is practiced at present.
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